Geri Grubbs, PHD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 40031 Sw Nelson Dr, Gaston, OR 97119 Phone: 503-747-5271 |
News Archive
Bellicum Pharmaceuticals, Inc. today announced $4.5 million in Series A and Convertible Note funding. The new funds will be used to complete the company's ongoing Phase I/IIa trial of BP-GMAX-CD1 in patients with advanced, androgen independent prostate cancer, and to prepare for Phase IIb trials. The company anticipates reporting initial results of the Phase I/IIa trial in mid 2010.
Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.
Could air pollution from traffic play a role in whether a child develops autism or ADHD? A team of investigators, led by UWM epidemiologist Amy Kalkbrenner, has landed a $2.3 million grant from the National Institute of Environmental Health Sciences to further explore this connection.
"This is a historic day for HIV prevention research. The CAPRISA 004 results are the first clinical evidence that a microbicide gel can help to prevent sexual transmission of HIV infection," said AVAC Executive Director Mitchell Warren, reacting to the results of the landmark microbicide trial presented today at the International AIDS Conference in Vienna.
› Verified 7 days ago